Health3 hours ago
Sarepta Secures Debt Refinancing as FDA Defers Eylea HD Review
Sarepta Therapeutics has successfully completed a debt refinancing deal, allowing the biotechnology firm to restructure its financial obligations. This move comes amidst ongoing challenges with the...